Rajasekar, Arvina
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Association of salivary retinol-binding protein 4 levels with periodontal disease in obese and nonobese individuals: A case–control study Thaha, Mohamed; Rajasekar, Arvina
Dental Journal (Majalah Kedokteran Gigi) Vol. 59 No. 2 (2026): June
Publisher : Faculty of Dental Medicine, Universitas Airlangga https://fkg.unair.ac.id/en

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/j.djmkg.v59.i2.p155-159

Abstract

Background: Periodontitis is an inflammatory infectious disease influenced by systemic inflammation, with obesity playing a key role in affecting human health and well-being. Retinol-binding protein 4 (RBP4), an adipokine elevated in obesity, is involved in inflammatory signaling and may serve as a biomarker for periodontal disease. While previous studies assessed serum RBP4, saliva offers a noninvasive, site-specific medium. Evaluating salivary RBP4 may provide insights into periodontal medicine and obesity-associated inflammation. Purpose: To evaluate and compare salivary RBP4 levels in obese and nonobese individuals and examine their relationship with clinical periodontal indicators. Methods: This cross-sectional, case-control study consisted of 50 systemically healthy individuals (25 obese and 25 nonobese), aged 25–50 years. Probing pocket depth (PPD) and clinical attachment level (CAL) were assessed. Unstimulated saliva samples were obtained, and RBP4 levels were determined via enzyme-linked immunosorbent assay. Statistical analyses involved independent t-tests and Pearson’s correlation. Results: Obese individuals showed substantially higher mean PPD (6.46 ± 1.02 mm), CAL (7.97 ± 1.46 mm), and salivary RBP4 concentration (24.18 ± 2.54 ng/mL) compared with their nonobese counterparts (PPD: 3.72 ± 0.12 mm; CAL: 4.02 ± 0.02 mm; RBP4: 9.26 ± 1.62 ng/mL) (p < 0.05). A strong, statistically significant correlation was found between RBP4 levels and both PPD and CAL in both groups (p < 0.05). Conclusion: Salivary RBP4 concentrations were elevated in obese individuals, with a strong correlation to periodontal clinical indices. These findings suggest that salivary RBP4 may have potential as a noninvasive indicator of inflammatory activity in obesity-associated periodontal disease, warranting further investigation in larger, longitudinal studies.
Therapeutic potential of thymoquinone gel in stage II grade A periodontitis: a prospective clinical and biochemical evaluation Nedumaran, Nivedha; Rajasekar, Arvina
Dental Journal (Majalah Kedokteran Gigi) Vol. 59 No. 2 (2026): June
Publisher : Faculty of Dental Medicine, Universitas Airlangga https://fkg.unair.ac.id/en

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/j.djmkg.v59.i2.p172-177

Abstract

Background: Periodontitis is a chronic inflammatory oral disease influenced by microbial plaque and oxidative stress, affecting human health and wellbeing. Conventional therapy with scaling and root planing (SRP) may benefit from adjunctive medicine with antioxidant and anti-inflammatory properties. Thymoquinone, derived from Nigella sativa, has shown promise in modulating oxidative stress and inflammation. However, there is limited clinical evidence regarding its adjunctive use in non-surgical periodontal therapy. Purpose: This clinical study aimed to evaluate the efficacy of 0.2% thymoquinone gel as an adjunct to SRP in treating stage II grade A periodontitis. Methods: Thirty patients diagnosed with stage II grade A periodontitis were randomly divided into two groups: Group 1 (Control), receiving SRP alone (n = 15), and Group 2 (Test), receiving SRP with 0.2% thymoquinone gel (n = 15). Clinical parameters, including the gingival index (GI), plaque index (PI), clinical attachment level (CAL), and probing pocket depth (PPD), were assessed. Additionally, oxidative stress index (OSI), total antioxidant capacity (TAOC), and total oxidant status (TOS) were measured in unstimulated saliva samples. Evaluations were conducted at baseline and three months post-treatment. Statistical analyses were employed to compare outcomes within and between groups. Results: Both groups demonstrated significant intragroup improvements (p < 0.05) in TOS, TAOC, CAL, PPD, GI, PI, and OSI from baseline to three months. However, intergroup comparisons revealed that Group 2 showed significantly greater improvement (p < 0.05) in all parameters except PI, which remained statistically insignificant (p > 0.05). Conclusion: The adjunctive use of 0.2% thymoquinone gel with SRP resulted in significantly greater improvements in clinical parameters (PPD, CAL, GI) and salivary oxidative stress markers (TOS, OSI, TAOC) compared with SRP alone. The study supports the potential role of thymoquinone as an adjunctive antioxidant agent in improving nonsurgical management of stage II grade A periodontitis.